Skip to main content
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;7(2):86–91. doi: 10.1111/j.1542-474X.2002.tb00147.x

Randomized Study of Early Intravenous Esmolol Versus Oral Beta‐Blockers in Preventing Post‐CABG Atrial Fibrillation in High Risk Patients Identified by Signal‐Averaged ECG: Results of a Pilot Study

Nomeda Balcetyte‐Harris 1, Jacqueline E Tamis 1, Peter Homel 2, Edith Menchavez 1, Jonathan S Steinberg 1
PMCID: PMC7027609  PMID: 12049678

Abstract

Background: Patients with prolonged signal‐averaged ECG have four times higher risk for development of atrial fibrillation (AF) after coronary artery bypass surgery (CABG). Incidence of AF is reduced, but not eliminated by prophylaxis with beta‐blockers. The limitations of prophylaxis with oral beta‐blockers may be related to the delayed effect of oral therapy. We performed a pilot study of the efficacy of early intravenous esmolol and an oral beta‐blocker regimen for prevention of postoperative AF.

Methods: Fifty patients referred for CABG and considered to be at high risk for postoperative AF on the basis of prolonged signal‐averaged ECG P wave duration > 140 ms were randomized to receive either a 24‐hour infusion of esmolol 6–18 hours after CABG, at an average dose 67 ± 7 μ/kg/min, followed by oral beta‐blockers versus oral beta‐blockers only beginning on postoperative day 1.

Results: Seven of 27 patients (26%) in the esmolol group and 6 of 23 patients (26%) in the oral beta‐blocker group developed postoperative AF, P = NS. The mean time of onset of AF (2.7 ± 0.5 vs 2.7 ± 0.3 postoperative day, P = NS) and the median duration of AF (10 [2192] vs 7 [1.16] hours, P = NS) were similar between the two groups. Eleven (41%) patients treated with esmolol developed adverse events (hypotension: 8, bradycardia requiring temporary pacing: 2, left ventricular failure:1 patient) as compared to only one patient (4%) in the beta‐blocker group who developed hypotension, P = 0.006.

Conclusions: This randomized controlled pilot study suggests that intravenous esmolol is less well tolerated and offers no advantages to standard beta‐blocker in preventing AF after CABG.

A.N.E. 2002;7(2):86–91

Keywords: atrial fibrillation, prevention, signal‐averaged ECG, coronary artery bypass grafting, esmolol, beta adrenergic receptor antagonists

REFERENCES

  • 1. Mitchell LB. Incidence, Timing and Outcome of Atrial Tachyarrhythmias After Cardiac Surgery Chapter in Steinberg JS. (ed): Atrial Fibrillation after Cardiac Surgery. Boston , Kluwer Academic Publishers, 2000, pp. 37–49. [Google Scholar]
  • 2. Tamis JE, Steinberg JS. The Impact of Atrial Fibrillation on Hospital Length of Stay After Cardiac Surgery Chapter in Steinberg JS. (ed): Atrial Fibrillation after Cardiac Surgery. Boston , Kluwer Academic Publishers, 2000, pp. 81–93. [Google Scholar]
  • 3. Ehlert FA, Narula DD, Steinberg JS. Risk Factors for the Development of Postoperative Atrial Fibrillation Chapter in Steinberg JS. (ed): Atrial Fibrillation after Cardiac Surgery. Boston , Kluwer Academic Publishers, 2000, pp. 51–80. [Google Scholar]
  • 4. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of P wave signal‐averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993;88:2618–2622. [DOI] [PubMed] [Google Scholar]
  • 5. Stafford PJ, Kolvekar S, Cooper J, et al. Signal‐averaged P wave compared with standard electrocardiography or echocardiography for prediction of atrial fibrillation after coronary bypass grafting. Heart 1997;77:417–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta‐analysis of randomized controlled trials. Circulation 1991;84(Suppl III):236–245. [PubMed] [Google Scholar]
  • 7. Kowey PR, Taylor JE, Rials SJ, et al. Meta‐analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmias early after coronary artery bypass grafting. Am J Cardiol 1992;69:963–965. [DOI] [PubMed] [Google Scholar]
  • 8. Sanchez JE, Epstein AE. Prophylactic Value of Beta Blockers Chapter in Steinberg JS. (ed): Atrial Fibrillation after Cardiac Surgery. Boston , Kluwer Academic Publishers, 2000, pp. 95–107. [Google Scholar]
  • 9. Hammond JW Jr, Wood AJ, Prager RL, et al. Perioperative beta blockade with propranolol: Reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmia. Ann Thorac Surg 1984;38:363–367. [DOI] [PubMed] [Google Scholar]
  • 10. Gray RJ, Bateman TM, Czer LSC, et al. Esmolol: A new ultrashort‐acting beta‐adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol 1985;5:1451–1456. [DOI] [PubMed] [Google Scholar]
  • 11. Ko W‐J, Chu S‐H. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. J Am Coll Cardiol 1994;23:302–306. [DOI] [PubMed] [Google Scholar]
  • 12. Reves JG, Croughwell ND, Hawkins E, et al. Esmolol for treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Thorac Cardio-vasc Surg 1990;100:221–227. [PubMed] [Google Scholar]
  • 13. Efron B. The jackknife, the bootstrap, and other resampling plans. Philadelphia ; Society for Industrial and Applied Mathematics, 1982, pp. 27–38. [Google Scholar]
  • 14. Abel RM, Van Gelder H, Pores IH, et al. Continued propranolol administration following coronary artery bypass surgery: Antiarrhythmic effects. Arch Surg 1983;118:727–731. [DOI] [PubMed] [Google Scholar]
  • 15. White HD, Antman EM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular arrhythmias after coronary bypass surgery. Circulation 1984;70:479–484. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES